Skip to main content
. 2019 Mar 1;9:3266. doi: 10.1038/s41598-019-39796-w

Figure 2.

Figure 2

VarClass Score for Selecting Pro-disease and Protective Variants. VarClass output showing True versus Mock (imputed) variants distribution using IDI score for the validation cohorts GSE8055 (n = 928) and GSE8054 (n = 1189), known to be associated with Pancreatic Cancer. T-test results: t = 13.345 for df = 3212.6, and a p-value: < 2.2e-16. The brown gradient arrow and dashed lines show the selected cut-offs of 0.02 and −0.02 for pro-disease and protective variants respectively.